These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 8563493

  • 1. MHC class II antigen expression is increased in different forms of urticaria.
    Haas N, Iwen W, Grabbe J, Uchanska-Ziegler B, Czarnetzki BM.
    Int Arch Allergy Immunol; 1996 Feb; 109(2):177-82. PubMed ID: 8563493
    [Abstract] [Full Text] [Related]

  • 2. Expression of class II-MHC antigens in the dermis of patients with progressive systemic sclerosis.
    Gruschwitz M, Sepp N, Kofler H, Wick G.
    Immunobiology; 1991 Jun; 182(3-4):234-55. PubMed ID: 1833311
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticaria.
    Hermes B, Prochazka AK, Haas N, Jurgovsky K, Sticherling M, Henz BM.
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):307-14. PubMed ID: 9949323
    [Abstract] [Full Text] [Related]

  • 5. Beta 2-integrins in different forms of urticaria.
    Haas N, Iwen W, Grabbe J, Hamann K, Czarnetzki BM.
    Br J Dermatol; 1995 Jul; 133(1):48-53. PubMed ID: 7545421
    [Abstract] [Full Text] [Related]

  • 6. Nicotinamide and 3-aminobenzamide reduce interferon-gamma-induced class II MHC (HLA-DR and -DP) molecule expression on cultured human endothelial cells and fibroblasts.
    Otsuka A, Hanafusa T, Miyagawa J, Kono N, Tarui S.
    Immunopharmacol Immunotoxicol; 1991 Jul; 13(3):263-80. PubMed ID: 1834724
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Chronic idiopathic urticaria: infiltrating cells and related cytokines in autologous serum-induced wheals.
    Caproni M, Giomi B, Volpi W, Melani L, Schincaglia E, Macchia D, Manfredi M, D'Agata A, Fabbri P.
    Clin Immunol; 2005 Mar; 114(3):284-92. PubMed ID: 15721839
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Changes in the expression of major histocompatibility complex class II antigens in liver allograft rejection.
    Hubscher SG, Adams DH, Elias E.
    J Pathol; 1990 Oct; 162(2):165-71. PubMed ID: 2250195
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.
    Jo YS, Lee JC, Li S, Choi YS, Bai YS, Kim YJ, Lee IS, Rha SY, Ro HK, Kim JM, Shong M.
    Int J Cancer; 2008 Feb 15; 122(4):785-90. PubMed ID: 17957790
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.